Innoviva (INVA) Net Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 33.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.04% |
| Sep 30, 2025 | 19.99% |
| Jun 30, 2025 | 5.51% |
| Mar 31, 2025 | -2.58% |
| Sep 30, 2024 | 37.55% |
| Jun 30, 2024 | 29.29% |
| Mar 31, 2024 | -34.19% |
| Sep 30, 2023 | -54.41% |
| Jun 30, 2023 | -22.05% |
| Mar 31, 2023 | -58.60% |
| Sep 30, 2022 | 47.42% |
| Jun 30, 2022 | -4.55% |
| Mar 31, 2022 | 77.45% |
| Sep 30, 2021 | -42.35% |
| Jun 30, 2021 | -81.59% |
| Mar 31, 2021 | 40.74% |
| Dec 31, 2020 | -52.92% |
| Sep 30, 2020 | 82.97% |
| Jun 30, 2020 | 57.42% |
| Mar 31, 2020 | 20.92% |
| Dec 31, 2019 | 61.80% |
| Sep 30, 2019 | 52.82% |
| Jun 30, 2019 | 58.44% |
| Mar 31, 2019 | 33.31% |
| Dec 31, 2018 | -44.43% |
| Sep 30, 2018 | 18.31% |
| Jun 30, 2018 | 92.73% |
| Mar 31, 2018 | -44.88% |
| Dec 31, 2017 | -41.91% |
| Sep 30, 2017 | 28.50% |
| Jun 30, 2017 | -33.68% |
| Mar 31, 2017 | 62.51% |
| Dec 31, 2016 | 42.19% |
| Sep 30, 2016 | 10.28% |
| Jun 30, 2016 | 16.55% |
| Mar 31, 2016 | -26.89% |
| Dec 31, 2015 | 87.83% |
| Sep 30, 2015 | -13.18% |
| Jun 30, 2015 | -61.47% |
| Mar 31, 2015 | 51.20% |
| Dec 31, 2014 | -8.24% |
| Sep 30, 2014 | -46.88% |
| Jun 30, 2014 | 51.06% |
| Mar 31, 2014 | -5.66% |
| Dec 31, 2013 | -31.68% |
| Sep 30, 2013 | -60.46% |